[1]
2018. A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION. International Research Journal of Pharmacy. 9, 5 (May 2018), 90–99.